Despite the beneficial roles of prolactin on metabolic homeostasis, pathological increases in prolactin levels have been frequently associated with metabolic disturbances, namely, weight gain, obesity, hyperinsulinemia, and reduced insulin sensitivity, all considered important players in the pathogenesis of NAFLD [60]. The gene discussed is PRL; the disease is metabolic dysfunction-associated steatotic liver disease.